Treco Douglas A

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Treco Douglas A's trades of CRISPR Therapeutics AG's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-08 2025-08-06 B Purchase
94,474 -21.2%
236.77
US$2,656,785
94,474 -21.2% 236.77 US$2,656,785
2025-04-03 2025-04-02 S Sale
68,656 +6.4%
443.55
US$1,700,715
68,656 +6.4% 443.55 US$1,700,715
2024-04-03 2024-04-02 S Sale
83,971 +45.9%
110.57
US$4,462,279
83,971 +45.9% 110.57 US$4,462,279